Kelsen D - Search Results

1

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V, Brennan M. Kelsen D, et al. J Clin Oncol. 1992 Apr;10(4):541-8. doi: 10.1200/JCO.1992.10.4.541. J Clin Oncol. 1992. PMID: 1548519 Clinical Trial.

2

Combined-modality therapy in the treatment of local-regional esophageal cancer.

Saltz L, Kelsen D. Saltz L, et al. Among authors: kelsen d. Ann Oncol. 1992 Dec;3(10):793-9. doi: 10.1093/oxfordjournals.annonc.a058098. Ann Oncol. 1992. PMID: 1286042 Free article. Review. No abstract available.

3

A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site.

Kelsen D, Martin DS, Colofiore J, Sawyer R, Coit D. Kelsen D, et al. Cancer. 1992 Oct 1;70(7):1988-92. doi: 10.1002/1097-0142(19921001)70:7<1988::aid-cncr2820700730>3.0.co;2-k. Cancer. 1992. PMID: 1381991 Clinical Trial.

4

Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma.

Casper ES, Schwartz GK, Kelsen DP. Casper ES, et al. Among authors: kelsen dp. Invest New Drugs. 1992 Aug;10(3):205-9. doi: 10.1007/BF00877247. Invest New Drugs. 1992. PMID: 1385354 Clinical Trial.

5

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.

Casper ES, Schwartz GK, Johnson B, Kelsen DP. Casper ES, et al. Among authors: kelsen dp. Invest New Drugs. 1992 Nov;10(4):313-6. doi: 10.1007/BF00944187. Invest New Drugs. 1992. PMID: 1487406 Clinical Trial.

6

Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.

Rusch VW, Niedzwiecki D, Tao Y, Menendez-Botet C, Dnistrian A, Kelsen D, Saltz L, Markman M. Rusch VW, et al. Among authors: kelsen d. J Clin Oncol. 1992 Jun;10(6):1001-6. doi: 10.1200/JCO.1992.10.6.1001. J Clin Oncol. 1992. PMID: 1588364

7

Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma.

Markman M, Kelsen D. Markman M, et al. Among authors: kelsen d. J Cancer Res Clin Oncol. 1992;118(7):547-50. doi: 10.1007/BF01225271. J Cancer Res Clin Oncol. 1992. PMID: 1624547 Clinical Trial.

8

Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.

Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Minsky BD, et al. Among authors: kelsen dp. J Clin Oncol. 1992 Aug;10(8):1218-24. doi: 10.1200/JCO.1992.10.8.1218. J Clin Oncol. 1992. PMID: 1634912 Clinical Trial.

9

Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.

Kelsen DP, Minsky B, Smith M, Beitler J, Niedzwiecki D, Chapman D, Bains M, Burt M, Heelan R, Hilaris B. Kelsen DP, et al. J Clin Oncol. 1990 Aug;8(8):1352-61. doi: 10.1200/JCO.1990.8.8.1352. J Clin Oncol. 1990. PMID: 1696309 Clinical Trial.

10

A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors.

Bajorin D, Kelsen DP. Bajorin D, et al. Among authors: kelsen dp. Cancer Invest. 1990;8(2):135-41. doi: 10.3109/07357909009017558. Cancer Invest. 1990. PMID: 1698110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters